-
-
Pharma & Human Health -
Pharma & Human Health -
Pharma & Human Health -
Pharma & Human Health
Editor’s Choice
Editor's Choice
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by […]
Editor's Choice
Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
In the past 10 years, there has been significant interest in new classes of active pharmaceutical ingredients (APIs). These novel APIs include live biotherapeutics, which are used for microbiome targeting drugs, oral biologics like GLP1 […]
Editor's Choice
EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and […]
In Case you Missed it:
Pharma & Human Health
Connection among gut fungi, genetics and disease risk in humans identified
A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the fungal component of the human microbiome — known as the mycobiome — and risk of developing chronic […]
Pharma & Human Health
resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform
Resbiotic Nutrition, Inc., a physician-scientist founded health and wellness company, today announced it has raised a total of $14.5 million, including a recently concluded $8 million Series A round supported by major shareholders Sororibus Capital and Biostack […]
Animal Health
New strains of beneficial gut bacteria discovered in animals
A key group of beneficial gut microbes has been found to co-evolve alongside their animal hosts, opening the door to new targeted probiotic and dietary interventions for both animals and humans. In a study published […]
Pharma & Human Health
CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence
When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they’d stumbled upon a revolutionary tool researchers could use to edit the DNA of living […]
Pharma & Human Health
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
Persephone Biosciences, a pioneering biotech company focused on unlocking the potential of the microbiome to impact human health, today announced the launch of its first consumer product: a daily synergistic synbiotic for infants and toddlers. […]
Finance
EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment
Following the closure of Bacthera’s CDMO activities, Lallemand has acquired a broad range of state-of-the-art equipment to produce drug substances and drug products in anaerobic conditions, reinforcing its GMP Pharma production capabilities for next-generation strains. […]
Pharma & Human Health
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. Novonesis and Novo Nordisk have entered a research partnership […]
Editor's Choice
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by […]
